Plant ID: NPO30179
Plant Latin Name: Cassia occidentalis
Taxonomy Genus: Cassia
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
TSHR; | |
BLM; RECQL; ALOX15; HSD17B10; | |
PIM1; CSNK2A1; MAPK1; | |
ESR1; ESR2; | |
ELANE; | |
HIF1A; NFKB1; | |
MAPT; THPO; LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Protein Kinase | CSNK2A1 | Casein kinase II alpha | P68400 | CHEMBL3629 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Serine protease | ELANE | Leukocyte elastase | P08246 | CHEMBL248 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.611E-08 | 3.507E-04 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.765E-07 | 1.922E-03 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008283; cell proliferation | GO:0008284; positive regulation of cell proliferation | 9.215E-07 | 5.017E-03 | CSNK2A1, ELANE, ESR1, HIF1A, MAPK1, PIM1, THPO, TSHR |
MF | GO:0060089; molecular transducer activity | GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | 9.167E-07 | 5.017E-03 | ESR1, ESR2 |
BP | GO:0009987; cellular process | GO:0009966; regulation of signal transduction | 4.577E-06 | 9.969E-03 | ALOX15, BLM, CSNK2A1, ELANE, ESR1, ESR2, HIF1A, LMNA, MAPK1, MAPT, NFKB1, THPO |
MF | GO:0005488; binding | GO:0051879; Hsp90 protein binding | 3.930E-06 | 9.969E-03 | CSNK2A1, HIF1A, MAPT |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 4.736E-06 | 9.969E-03 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0034056; estrogen response element binding | 5.494E-06 | 9.969E-03 | ESR1, ESR2 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 5.494E-06 | 9.969E-03 | CYP2C9, CYP3A4 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 3.714E-05 | 2.311E-02 | HIF1A, MAPK1, MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.361E-08 | 1.796E-06 | CYP2C9, ALOX15, CYP3A4, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 5.744E-07 | 3.791E-05 | MAPK1, ESR1, NFKB1, ESR2 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 3.385E-06 | 1.489E-04 | CYP2C9, ALOX15, MAPK1, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 2.059E-05 | 6.795E-04 | PIM1, MAPK1, NFKB1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 2.653E-05 | 7.005E-04 | CYP2C9, ALOX15, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 3.660E-05 | 8.053E-04 | CYP2C9, CYP3A4, CYP2C19 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.142E-04 | 1.598E-03 | PIM1, MAPK1, NFKB1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 1.076E-04 | 1.598E-03 | MAPK1, ESR1, ESR2 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 6.139E-05 | 1.158E-03 | CYP2C9, CYP3A4, CYP2C19 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 1.211E-04 | 1.598E-03 | MAPK1, HIF1A, NFKB1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 1.811E-04 | 2.173E-03 | MAPK1, ESR1, HIF1A |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 2.996E-04 | 3.296E-03 | LMNA, MAPK1, NFKB1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 5.110E-04 | 5.189E-03 | MAPK1, MAPT, HSD17B10 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 8.855E-04 | 7.793E-03 | MAPK1, HIF1A, ESR1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 8.360E-04 | 7.793E-03 | MAPK1, NFKB1, TSHR |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; |